Delivery Order SPE2DR25D2001-SPE2DR26FBGC2
Award Date 12/22/25
Potential Completion Date 12/23/25
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count unit dose packages) valued at $49,686.94 under a firm fixed-price contract. The award, issued on November 7, 2025, with completion targeted for November 10, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $11,779.01 on November 18, 2025, for RINVOQ ER 15 mg tablets (30-count packages). This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 19, 2025, and performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $36,767.19 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on December 10, 2025, with completion targeted for December 11, 2025. This firm fixed price delivery order represents a non-competitive, non-set-aside award to the prime contractor under its existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,372.33 for RINVOQ ER 15 mg tablets (30-count units) on December 19, 2025, with an ultimate completion date of December 22, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) valued at $12,603.88 under a firm fixed-price contract. The award was made on December 3, 2025, with an ultimate completion date of December 4, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp will perform this order from its corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) valued at $13,841.99 under a firm fixed-price contract type. The award was made on August 22, 2025, with an ultimate completion date of August 25, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) valued at $9,914.76 under a firm fixed-price contract type. The award, issued on December 19, 2025, with an ultimate completion date of December 22, 2025, represents a non-competitive set-aside delivery order for pharmaceutical supply. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for RINVOQ ER 15 mg tablets in a quantity of 30 units, with a ceiling value of $17,417.68. This firm fixed-price delivery order, which has no set-aside designation, is set to be completed by December 9, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a pharmaceutical product used in the treatment of inflammatory conditions,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count unit) valued at $9,891.99 under a firm fixed-price contract type. This non-set-aside award, made on November 12, 2025, with an ultimate completion date of November 13, 2025, represents a procurement of pharmaceutical products to support federal medical supply needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) valued at $9,780.29 under a firm fixed-price contract type. The award, made on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate...